| Patent | Date |
|---|
Programmable pharmaceutical compositions for chrono drug release
Grant 11,439,585 - Vaka , et al. September 13, 2 | 2022-09-13 |
Programmable pharmaceutical compositions for chrono drug release
Grant 11,419,813 - Vaka , et al. August 23, 2 | 2022-08-23 |
Extended Release Compositions Comprising Trihexyphenidyl
App 20220249377 - Shelke; Namdev B. ; et al. | 2022-08-11 |
Gastroretentive Dosage Forms Of Levodopa And Carbidopa
App 20220241184 - MEGHPARA; Kanji ; et al. | 2022-08-04 |
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20220218604 - Meghpara; Kanji ; et al. | 2022-07-14 |
Delayed Release Methylphenidate Compositions
App 20220133635 - Vaka; Siva Ram Kiran ; et al. | 2022-05-05 |
Gastroretentive dosage forms for sustained drug delivery
Grant 11,318,091 - Meghpara , et al. May 3, 2 | 2022-05-03 |
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20220096366 - Vaka; Siva Ram Kiran ; et al. | 2022-03-31 |
Extended Release Compositions Comprising Pyridostigmine
App 20220096386 - Vaka; Siva Ram Kiran ; et al. | 2022-03-31 |
Delayed Release Methylphenidate Compositions
App 20220040114 - Vaka; Siva Ram Kiran ; et al. | 2022-02-10 |
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20220031604 - Shah; Navnit H. ; et al. | 2022-02-03 |
Extended release compositions comprising pyridostigmine
Grant 11,229,606 - Vaka , et al. January 25, 2 | 2022-01-25 |
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210393512 - Vaka; Siva Ram Kiran ; et al. | 2021-12-23 |
Self-regulating osmotic gastroretentive drug delivery systems
Grant 11,179,320 - Shah , et al. November 23, 2 | 2021-11-23 |
Programmable pharmaceutical compositions for chrono drug release
Grant 11,166,906 - Vaka , et al. November 9, 2 | 2021-11-09 |
Extended Release Compositions Comprising Trihexyphenidyl
App 20210330657 - Shelke; Namdev B. ; et al. | 2021-10-28 |
Extended release compositions comprising trihexyphenidyl
Grant 11,154,505 - Shelke , et al. October 26, 2 | 2021-10-26 |
Programmable pharmaceutical compositions for chrono drug release
Grant 11,154,494 - Vaka , et al. October 26, 2 | 2021-10-26 |
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20210236421 - Meghpara; Kanji ; et al. | 2021-08-05 |
Extended Release Compositions Comprising Pyridostigmine
App 20210236429 - Shelke; Namdev B. ; et al. | 2021-08-05 |
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210228474 - Vaka; Siva Ram Kiran ; et al. | 2021-07-29 |
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210205207 - Vaka; Siva Ram Kiran ; et al. | 2021-07-08 |
Extended release compositions comprising trihexyphenidyl
Grant 11,045,420 - Shelke , et al. June 29, 2 | 2021-06-29 |
Extended release compositions comprising trihexyphenidyl
Grant 11,040,014 - Shelke , et al. June 22, 2 | 2021-06-22 |
High-concentration Fulvestrant Compositions
App 20210145846 - Shah; Navnit H. ; et al. | 2021-05-20 |
Gastroretentive dosage forms for sustained drug delivery
Grant 11,007,145 - Meghpara , et al. May 18, 2 | 2021-05-18 |
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20210137827 - Shah; Navnit H. ; et al. | 2021-05-13 |
Programmable pharmaceutical compositions for chrono drug release
Grant 11,000,471 - Vaka , et al. May 11, 2 | 2021-05-11 |
Extended release compositions comprising pyridostigmine
Grant 10,987,311 - Vaka , et al. April 27, 2 | 2021-04-27 |
Programmable pharmaceutical compositions for chrono drug release
Grant 10,980,738 - Vaka , et al. April 20, 2 | 2021-04-20 |
Opioid agonist / antagonist combination dosage forms
Grant 10,960,001 - Shah , et al. March 30, 2 | 2021-03-30 |
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,952,957 - Shah , et al. March 23, 2 | 2021-03-23 |
Extended Release Compositions Comprising Pyridostigmine
App 20210069117 - Vaka; Siva Ram Kiran ; et al. | 2021-03-11 |
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20210052487 - Shah; Navnit H. ; et al. | 2021-02-25 |
Extended release compositions comprising pyridostigmine
Grant 10,925,833 - Shelke , et al. February 23, 2 | 2021-02-23 |
Gastroretentive dosage forms for sustained drug delivery
Grant 10,918,597 - Meghpara , et al. February 16, 2 | 2021-02-16 |
Extended Release Compositions Comprising Trihexyphenidyl
App 20210038523 - Shelke; Namdev B. ; et al. | 2021-02-11 |
Extended Release Compositions Comprising Trihexyphenidyl
App 20210038524 - Shelke; Namdev B. ; et al. | 2021-02-11 |
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20210030685 - Vaka; Siva Ram Kiran ; et al. | 2021-02-04 |
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20210022999 - Meghpara; Kanji ; et al. | 2021-01-28 |
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,898,430 - Shah , et al. January 26, 2 | 2021-01-26 |
Programmable pharmaceutical compositions for chrono drug release
Grant 10,898,431 - Vaka , et al. January 26, 2 | 2021-01-26 |
Extended release compositions comprising pyridostigmine
Grant 10,881,617 - Vaka , et al. January 5, 2 | 2021-01-05 |
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20200405626 - Vaka; Siva Ram Kiran ; et al. | 2020-12-31 |
Extended release compositions comprising trihexyphenidyl
Grant 10,869,839 - Shelke , et al. December 22, 2 | 2020-12-22 |
Extended Release Compositions Comprising Pyridostigmine
App 20200383923 - Shelke; Namdev B. ; et al. | 2020-12-10 |
Gastroretentive dosage forms for sustained drug delivery
Grant 10,857,098 - Meghpara , et al. December 8, 2 | 2020-12-08 |
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,849,846 - Shah , et al. December 1, 2 | 2020-12-01 |
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20200337998 - Meghpara; Kanji ; et al. | 2020-10-29 |
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200330368 - Shah; Navnit H. ; et al. | 2020-10-22 |
Extended Release Compositions Comprising Trihexyphenidyl
App 20200261372 - Shelke; Namdev B. ; et al. | 2020-08-20 |
Gastroretentive Dosage Forms For Sustained Drug Delivery
App 20200261359 - Meghpara; Kanji ; et al. | 2020-08-20 |
Extended release compositions comprising pyridostigmine
Grant 10,744,093 - Vaka , et al. A | 2020-08-18 |
Abuse-resistant drug formulations
Grant 10,744,131 - Sandhu , et al. A | 2020-08-18 |
Self-regulating osmotic gastroretentive drug delivery systems
Grant 10,744,083 - Shah , et al. A | 2020-08-18 |
Programmable Pharmaceutical Compositions For Chrono Drug Release
App 20200253861 - Kind Code | 2020-08-13 |
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200179267 - Shah; Navnit H. ; et al. | 2020-06-11 |
Extended Release Compositions Comprising Pyridostigmine
App 20200163889 - Vaka; Siva Ram Kiran ; et al. | 2020-05-28 |
Self-regulating Osmotic Gastroretentive Drug Delivery Systems
App 20200155446 - Shah; Navnit H. ; et al. | 2020-05-21 |
Abuse-resistant drug formulations with built-in overdose protection
Grant 10,632,113 - Vaka , et al. | 2020-04-28 |
Extended release compositions comprising pyridostigmine
Grant 10,588,863 - Vaka , et al. | 2020-03-17 |
Extended Release Compositions Comprising Pyridostigmine
App 20190388351 - Vaka; Siva Ram Kiran ; et al. | 2019-12-26 |
Extended Release Compositions Comprising Pyridostigmine
App 20190374473 - Vaka; Siva Ram Kiran ; et al. | 2019-12-12 |
Supersaturated stabilized nanoparticles for poorly soluble drugs
Grant 10,500,282 - Desai , et al. Dec | 2019-12-10 |
Opioid Agonist / Antagonist Combination Dosage Forms
App 20190358221 - Shah; Navnit H. ; et al. | 2019-11-28 |
Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
App 20190343957 - Vaka; Siva Ram Kiran ; et al. | 2019-11-14 |
Extended Release Drug Formulation With Overdose Protection And Abuse Deterrence
App 20190282508 - Shah; Navnit H. ; et al. | 2019-09-19 |
Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage forms
Grant 10,406,234 - Vaka , et al. Sept | 2019-09-10 |
Orally Disintegrating Tablet Formulation For Enhanced Bioavailability
App 20190083403 - Djordjevic; Jelena ; et al. | 2019-03-21 |
Overdose Protection And Abuse Deterrent Immediate Release Drug Formulation
App 20190054031 - Shah; Navnit H. ; et al. | 2019-02-21 |
Orally disintegrating tablet formulation for enhanced bioavailability
Grant 10,195,150 - Djordjevic , et al. Fe | 2019-02-05 |
Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof
App 20190030006 - Shah; Navnit H. ; et al. | 2019-01-31 |
Formulations, Methods, Kits, And Dosage Forms For Treating Atopic Dermatitis And For Improved Stability Of An Active Pharmaceutical Ingredient
App 20190008868 - Railkar; Aruna ; et al. | 2019-01-10 |
Enhanced Abuse-deterrent Formulations Of Oxycodone
App 20180303757 - Banerjee; Siddhartha ; et al. | 2018-10-25 |
Food Independent Immediate Release Drug Formulation With Abuse Deterrence And Overdose Protection
App 20180296486 - Shah; Navnit H. ; et al. | 2018-10-18 |
Surfactant-free HIV protease inhibitor composition and method of manufacturing thereof
Grant 10,034,865 - Shah , et al. July 31, 2 | 2018-07-31 |
Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms
App 20170173157 - VAKA; Siva Ram Kiran ; et al. | 2017-06-22 |
Surfactant-free Hiv Protease Inhibitor Composition And Method Of Manufacturing Thereof
App 20170071915 - SHAH; NAVNIT H. ; et al. | 2017-03-16 |
Self-nanoemulsion of poorly soluble drugs
Grant 9,511,078 - Desai , et al. December 6, 2 | 2016-12-06 |
Abuse-resistant Drug Formulations With Built-in Overdose Protection
App 20160346274 - Vaka; Siva Ram Kiran ; et al. | 2016-12-01 |
Abuse-resistant Drug Formulations
App 20160317530 - Sandhu; Harpreet Kaur ; et al. | 2016-11-03 |
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
Grant 9,370,492 - Ahmed , et al. June 21, 2 | 2016-06-21 |
Self-nanoemulsion Of Poorly Soluble Drugs
App 20160151392 - Desai; Dipen ; et al. | 2016-06-02 |
Orally Disintegrating Tablet Formulation For Enhanced Bioavailability
App 20160120809 - Djordjevic; Jelena ; et al. | 2016-05-05 |
Supersaturated Stabilized Nanoparticles For Poorly Soluble Drugs
App 20150335753 - Desai; Dipen ; et al. | 2015-11-26 |
Pharmaceutical composition and process
Grant 7,795,237 - Ahmed , et al. September 14, 2 | 2010-09-14 |
Solid Pharmaceutical Dosage Forms Comprising Bisphosphonates And Modified Amino Acid Carriers
App 20090281064 - Ahmed; Hashim ; et al. | 2009-11-12 |
Saquinavir Mesylate Oral Dosage Form
App 20090054481 - Albano; Antonio A. ; et al. | 2009-02-26 |
Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers
App 20080107725 - Albano; Antonio Aquino ; et al. | 2008-05-08 |
Pharmaceutical composition and process
App 20070202175 - Ahmed; Hashim A. ; et al. | 2007-08-30 |
Solid pharmaceutical dosage forms comprising bisphosphonates and modified amino acid carriers
App 20070049557 - Ahmed; Hashim ; et al. | 2007-03-01 |
High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same
Grant 7,014,866 - Infeld , et al. March 21, 2 | 2006-03-21 |
Saquinavir mesylate oral dosage form
App 20050009811 - Albano, Antonio A. ; et al. | 2005-01-13 |
High dose solid unit oral pharmaceutical dosage form of amorphous nelfinavir mesylate and process for making same
App 20030021840 - Infeld, Martin Howard ; et al. | 2003-01-30 |
Amorphous Form Of Cell Cycle Inhibitor Having Improved Solubility And Bioavailability
App 20020173534 - Albano, Antonio A. ; et al. | 2002-11-21 |
Amorphous Form Of Cell Cycle Inhibitor Having Improved Solubility And Bioavailability
App 20020173533 - Albano, Antonio A. ; et al. | 2002-11-21 |
Amorphous Form Of Cell Cycle Inhibitor Having Improved Solubility And Bioavailability
App 20020173532 - Albano, Antonio A. ; et al. | 2002-11-21 |
Amorphous Form Of Cell Cycle Inhibitor Having Improved Solubility And Bioavailability
App 20020156119 - Albano, Antonio A. ; et al. | 2002-10-24 |
Amorphous form of cell cycle inhibitor having improved solubility and bioavailability
App 20020061922 - Albano, Antonio A. ; et al. | 2002-05-23 |
Stable complexes of poorly soluble compounds in ionic polymers
Grant 6,350,786 - Albano , et al. February 26, 2 | 2002-02-26 |
Colon targeted delivery system
Grant 6,039,975 - Shah , et al. March 21, 2 | 2000-03-21 |
Colon-targeted delivery system
Grant 5,482,718 - Shah , et al. January 9, 1 | 1996-01-09 |
Pharmaceutical compositions with constant erosion volume for zero order controlled release
Grant 5,393,765 - Infeld , et al. February 28, 1 | 1995-02-28 |
| 